Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,390,891
+$125,372 QoQ
Shares Held
9,364
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,012
of 3,140 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $52,280,324 across 9 Drug Manufacturers - General names. AMGN ranks #8 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
87,982 | $11,305,687 | |
| 2 | ABBV |
AbbVie Inc.
|
31,610 | $7,954,340 | |
| 3 | LLY |
ELI LILLY & Co
|
5,597 | $6,713,210 | |
| 4 | AZN |
Astrazeneca PLC
|
32,868 | $6,232,430 | |
| 5 | JNJ |
Johnson & Johnson
|
24,292 | $6,169,439 | |
| 6 | NVO |
Novo Nordisk A S
|
107,307 | $5,144,297 | |
| 7 | NVS |
Novartis AG
|
30,427 | $4,768,519 | |
| 8 | AMGN |
Amgen Inc
This page
|
9,364 | $3,390,891 |
All Filings in AMGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,390,891 | 9,364 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,265,519 | 9,281 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,062,639 | 9,357 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,621,920 | 9,291 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,620,944 | 9,387 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,831,054 | 9,087 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,368,435 | 9,087 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $2,875,079 | 8,923 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,923,754 | 6,157 | Shares | Sole | 2024-07-30 | |
| 2023-06-30 | $1,595,879 | 7,188 | Shares | Sole | 2024-04-01 | |
| 2023-03-31 | $1,697,568 | 7,022 | Shares | Sole | 2024-04-01 | |
| 2022-12-31 | $1,819,569 | 6,928 | Shares | Sole | 2024-04-01 | |
| 2022-09-30 | $3,639,083 | 16,145 | Shares | Sole | 2024-04-01 | |
| 2022-06-30 | $3,895,233 | 16,010 | Shares | Sole | 2024-04-01 | |
| 2022-03-31 | $1,633,977 | 6,757 | Shares | Sole | 2024-04-01 | |
| 2021-12-31 | $1,256,457 | 5,585 | Shares | Sole | 2024-04-01 | |
| 2021-09-30 | $2,825,693 | 13,288 | Shares | Sole | 2024-04-01 | |
| 2021-06-30 | $3,091,481 | 12,683 | Shares | Sole | 2024-04-01 | |
| 2021-03-31 | $3,072,554 | 12,349 | Shares | Sole | 2024-04-01 | |
| 2020-12-31 | $2,769,386 | 12,045 | Shares | Sole | 2024-04-01 | |
| 2020-09-30 | $2,722,307 | 10,711 | Shares | Sole | 2024-04-01 | |
| 2020-06-30 | $2,157,647 | 9,148 | Shares | Sole | 2024-04-01 | |
| 2020-03-31 | $1,238,072 | 6,107 | Shares | Sole | 2024-04-01 | |
| No filing history on record for this holder in this stock. | ||||||